维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="DILETTI"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Impact of biodegradable versus durable polymer drug-eluting stents on clinical outcomes in patients with coronary artery disease: a meta-analysis of 15 randomized trials显示文摘	Zhang Yaojun Tian Nailiang Dong Shengjie Ye Fei Li Minghui Christos V.Bourantas Javaid Iqbal Yoshinobu Onuma Takashi Muramatsu Roberto Diletti Hector M. Garcia-Garcia Xu Bo Patrick W. Serruys Chen Shaoliang	2014	Chinese Medical Journal2014，，11：	3
2	Agreement and re- producibility of gray-scale intravascular ultrasound and optical coherence tomography for the analysis of the bioresorbable vas- cular scaffold显示文摘	Gomez-Lara J Brugaletta S Diletti R	2012	Catheter Cardiovasc Interv2012，79，：	1
3	Population pharmacokinetic modelling of roflumilast and roflumilast N-Oxide by total phosphodiesterase 4 inhibitory activity and development of a population pharmacodynamic adverse event model 显示文摘	Lahu G H0nnemeyer A Diletti E	2010	Clin Pharmacokinet2010，49，9：	1
4	Presentation of results from bioequivalenee studies显示文摘	SAUTER R STEINIJANS VW DILETTI E	1992	Int J Clin Pharmacol Ther Toxicol1992，30，1：	1
5	Population phamlacokinetic modelling of roflumilast and roflumilast N-oxide by total phosphodiesterase-4 inhibitory activity and development of a population pharmacodynamic-adverse event model 显示文摘	Lahu G Hunnemeyer A Diletti E	2010	Clin Pharmacokinet2010，49，9：	1
6	Comparison of in vivo eccentricity and symmetry indices between metallic stents and bioresorbable vascular scaffolds: insights from the ABSORB and SPIRIT trials显示文摘	Bruqaletta S Gomez-Lara J Diletti R	2012	Catheter Cardiovasc Interv2012，79，2：	1
7	Sample size determination for proving equivalence based on the ratio of two means for normally distributed data 显示文摘	Hauschke D Kieser M Diletti E	1999	Stat Med1999，18，：	1
8	Statistical Analysis of Bioavailability Studies:Parametric and Nonparametric Confidence Intervals显示文摘	Steinijans VW Diletti E	1983	Eur J Clin Pharmacol1983，24，1：	1
9	ABSORB Ⅱ randomized controlled trial:A clinical evaluation to compare the safety,efficacy,and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions:Rationale and study design显示文摘	Diletti R Serruys PW Farooq V	2012	AM Heart J2012，164，5：	1
10	Relative bioavailability of different valproic acid formulations显示文摘	Diletti E Hoffmann C	1995	Int J Clin Pharmacos Ther1995，33，12：	1
11	Relative bioavailability of different valproic acid formulations显示文摘	Frank G Diletti E Hoffmann C	1995	Int j Clin Pharmacol Ther1995，33，12：	1
12	ABSORB Ⅱ randomized controlled trial:a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions:rationale and study design显示文摘	Diletti R Serruys PW Farooq V	2012	Am Heart J2012，164，5：	1
13	Vascular response of the segments adjacent to the proximal and distal edges of the absorb everolimus-eluting bioresorbable vascular scaffold:6-month and I-year follow-up assessment:a virtual histology intravascular ultrasound study from the first-in-man ABSORB cohort B trial显示文摘	Gogas BD Serruys PW Diletti R	2012	JACC Cardiovasc Interv2012，5，6：	1
14	Iso-tope dilution determination of polycyclic aromatic hydrocar-bons in olive pomace oil by gas chromatography-massspectrometry显示文摘	DILETTI G SCORTICHINI G SCARPONE R	2005	Journal of Chromatography A2005，1062，：	1
15	Left radial versus fight radial approach for coronary artery catheterization: a prospective comparison 显示文摘	Dominici M Diletti R Milici C	2012	J lnterv Cardiol2012，25，2：	1
16	Operator exposure to x-ray in left and right radial access during percutaneous coronary proce- dures : OPERA randomised study 显示文摘	Dominiei M Diletti R Miliei C	2013	Heart2013，，99：	1
17	A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds显示文摘	GOMEZ-LARA J BRUGALETTA S DILETTI R	2011	European Heart Journal2011，32，3：	1
18	Population pharmaeokinetie modelling of roflumilast and roflumilast Noxide by total phosphodiesterase-4 inhibitory activity and development of a population pharmaeodynamie-adverse event model显示文摘	LAHU G HUNNEMEYER A DILETTI E	2010	Clin Pharmacokinet2010，49，9：	1
19	Statistical analysis of bioavailability studies:parametric and nonparametric confidence intervals显示文摘	STEINIJANS VW DILETTI E		0，，01：	1
20	Assessment of coronary atheroseIerosis progression and regression at bifurcations using combined 1VUS and OCT 显示文摘	Diletti R Garcia HM Gomez LJ	2011	JACC: Cardiovascular Imaging2011，4，7：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示